Hypersensitivity to Aloe

Archives of Dermatology

Volumn 116, Issue 9, 1980, Pages 1064-1065

  Morrow, David M ^a   Rapaport, Marvin J ^a   Strick, Richard A ^a  

^a UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRAQUINONE DERIVATIVE; EMODIN; ALLERGEN; ALOE; TRIAMCINOLONE ACETONIDE;

ADULT; ALOE; ARTICLE; CASE REPORT; CONTACT DERMATITIS; DRUG HYPERSENSITIVITY; HUMAN; IATROGENIC DISEASE; IMMUNOLOGY; MALE; MEDICINAL PLANT; SKIN DISEASE; URTICARIA; CONTACT URTICARIA; DERMATITIS; DIAGNOSIS; ECZEMA; HYPERSENSITIVITY; ORAL DRUG ADMINISTRATION; PAPULAR ACRODERMATITIS; PATCH TEST; TOPICAL DRUG ADMINISTRATION;

ALOE; ANTHRAQUINONES; CASE REPORT; DERMATITIS, CONTACT; DRUG HYPERSENSITIVITY; EMODIN; HUMAN; MALE; MIDDLE AGE; PLANTS, MEDICINAL; SKIN DISEASES; URTICARIA;

EID: 0019225730     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archderm.1980.01640330102026     Document Type: Article

References (18)

1. Mitchell J, Rook A: Botanical Dermatology. Vancouver, Canada, Greenglass Limited, 1979, pp 438-439.
2. Fujita K, Suzuki I, Ochiai J, et al: Specific reaction of aloe extract with serum proteins of various animals. Experientia 34:523-524, 1978.
3. Tyler VE, Brady LR, Robbers JE: Pharmacognosy, ed 1. Philadelphia, Lea & Febiger, 1976, pp 81-83.
4. Kupchan SM, Karim A: Tumor inhibitors: 114. Aloe emodin: Antileukemic principle isolated from Rhamnus frangula L. Lloydia 39:223-224, 1976.
5. Fujita K, Teradaira R, Nagatsu T: Bradykinase activity of aloe extract. Biochem Pharmacol 25:205, 1976.
6. Hirata T, Suga T: Biologically active constituents of leaves and roots of Aloe arborescens var. natalensis. Z Naturforsch 32:731-734, 1977.
7. Sauchak UI: Acute bullous allergic dermatitis due to local application of aloe leaves. Vestn Dermatol Venerol 12:44-45, 1977.
8. Fisher AA: Contact Dermatitis. Philadelphia, Lea & Febiger, 1975, pp 283-286.
9. Sulzberger MB: Hypersensitiveness to arsphenamine in guinea-pigs: I. Experiments in prevention and desensitization. Arch Dermatol Syphilol 20:669-697, 1929.
10. Chase MW: Inhibition of experimental drug allergy by prior feeding of the sensitizing agent. Proc Soc Exp Biol Med 61:257-259, 1946.
11. Lowrey ED: Immunologic unresponsiveness to a contact sensitizer in man. J Invest Dermatol 51:411-417, 1968.
12. Van Scott EJ, Kalmanson JD: Complete remission of mycosis fungoides lymphoma induced by topical nitrogen mustard (HN2): Control of delayed hypersensitivity to HN, by desensitization and by induction of specific immunologic tolerance. Cancer 32:18-30, 1973.
13. Baer RL, Michaelidos P, Presita AE: Failure to induce immune tolerance to nitrogen mustard: Intravenous administration preceding topical use in patients with psoriasis. J Invest Dermatol 58:1-4, 1972.
14. Taylor JR, Halprin KM: Topical use of mechlorethamine in the treatment of psoriasis. Arch Dermatol 106:362-364, 1972.
15. Breza TS, Kechijian P, Taylor JR: Mechlorethamine in psoriasis: Further attempts to induce immunologic tolerance. Arch Dermatol 111:1438-1439, 1975.
16. Leshaw S, Simon RS, Baer RL: Failure to induce tolerance to mechlorethamine hydrochloride. Arch Dermatol 113:1406-1408, 1977.
17. Kligman AM: Hyposensitization against Rhus dermatitis. Arch Dermatol Syphilol 78:47-72, 1958.
18. Fisher AA: Some immunologic phenomena in treatment of and patch testing for ragweed oil dermatitis. J Invest Dermatol 19:271-279, 1952.